Navigation Links
Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2009

ST. LOUIS, April 27 /PRNewswire-FirstCall/ -- Young Innovations, Inc. (Nasdaq: YDNT) today announced results for the quarter ended March 31, 2009.

Sales for the first quarter of 2009 were $23.8 million, a decrease of $0.6 million or 2.6% from the $24.4 million reported in the first quarter of 2008. Income from operations increased 9.3% to $5.0 million in the first quarter of 2009 from $4.6 million in the first quarter of 2008. Net income increased 11.4% to $3.2 million compared with $2.8 million in the first quarter of 2008. Diluted earnings per share increased 17.6% in the first quarter of 2009 to $0.40 from $0.34 in the prior year quarter. Diluted earnings per share were affected by equity compensation expense of $0.03 for the quarter ending March 31, 2009, remaining unchanged from the prior year quarter. Results in the first quarter of 2008 also included a one-time foreign exchange benefit of approximately $300,000, or $0.02 per share, related to the repayment of debt from the Company's Irish subsidiary.

Continuing a trend over the past several quarters, demand for our consumable products remained solid in the first quarter despite the economic downturn but was offset by continued weakness in our diagnostic product line. Sales of our consumable products, which include our preventive, infection control, endodontic, micro-applicator and home care product lines, remained essentially flat over the prior year quarter. We believe the weak economic climate contributed to disappointing results in our diagnostic product line, which posted results $530,000 below that of the first quarter of 2008. Sales were also negatively impacted by approximately $264,000 as the U.S. dollar continued to strengthen in the first quarter. Increased gross and operating margins were driven primarily by shifting product mix, price increases introduced in the second half of 2008 and the benefits of operating efficiencies implemented in 2008, including facility consolidations and adjusted staff levels.

Despite the challenges of the current environment, we have remained committed to our core operating strategies of enhancing and expanding customer relationships, improving operating efficiencies and expanding our product offering through internal development and acquisitions. In the first quarter, we made continued progress on enhancing the effectiveness of our sales and marketing organization, implemented incremental operating efficiency improvements in a number of our facilities and expanded our preventive and infection control product offerings with the addition of a new hand-piece and new surface disinfectant.

We are encouraged by the first quarter results. We are pleased that, despite the weak economy, we were able to show significant improvement in operating results following efforts to restructure the business over the past few years. While ongoing changes in product mix and costs related to new product introductions are expected to continue to impact quarterly results, we believe we are well-positioned to more aggressively compete and grow our business.

A conference call has been scheduled for Tuesday, April 28, 2009 at 11:00 A.M. Central Time and can be accessed through InterCall at or on the Company's website,

Young Innovations develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, panoramic X-ray machines, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and children's toothpastes. The Company believes it is a leading U.S. manufacturer or distributor of prophy angles and cups, liquid surface disinfectants, dental micro-applicators and obturation units designed for warm, vertical condensation.

Investors are cautioned that this press release as well as other reports and oral statements by Company officials may contain certain forward-looking statements as defined in the Private Securities Litigation and Reform Act of 1995. Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions and which include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," or similar expressions. These statements are not guaranties of future performance and the Company makes no commitment to update or disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements. Because such statements involve risks and uncertainties, actual actions and strategies and the timing and expected results thereof may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, those disclosed in the Company's Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

                  Young Innovations, Inc.
                Consolidated Balance Sheet
           March 31, 2009 and December 31, 2008
           (in thousands, except per share data)

                                 March 31   December 31
             Assets                2009         2008
                                   ----         ----
    Current assets
      Cash                          $728         $667
      Accounts receivable, net    12,549       10,421
      Inventories                 16,419       16,486
      Other current assets         4,799        4,759
                                   -----        -----
    Total current assets          34,495       32,333
                                  ------       ------

    Property, plant and
     equipment, net               33,367       32,905
    Goodwill                      80,284       80,334
    Other intangible assets       12,162       10,602
    Other assets                   3,378        3,402
                                   -----        -----

    Total assets                $163,686     $159,576
                                ========     ========

     Liabilities and Equity
    Current liabilities
      Accounts payable and
       accrued liabilities       $10,256       $8,840
                                 -------       ------
    Total current
     liabilities                  10,256        8,840
                                  ------        -----

    Long-term debt                29,075       29,349
    Long-term secured
     borrowing                     1,226        1,281
    Deferred income taxes         13,771       13,829
    Other noncurrent
     liabilities                     272            -
                                     ---          ---
    Total liabilities             54,600       53,299
                                  ------       ------

    Stockholders' equity
      Common stock                   102          102
      Additional paid-in
       capital                    23,421       25,336
      Retained earnings          136,381      133,531
      Common stock in
       treasury, at cost         (50,690)     (52,673)
      Accumulated other
       comprehensive loss           (128)         (19)
                                    ----          ---
    Total stockholders' equity   109,086      106,277

    Total liabilities and
     stockholders' equity       $163,686     $159,576
                                ========     ========

                        Young Innovations, Inc.
                   Consolidated Statements of Income
                 (in thousands, except per share data)

                                          Three Months Ended
                                              March 31,
                                            2009     2008  Change
                                            ----     ----  ------

    Net Sales                             $23,764  $24,395    -2.6%
    Cost of Goods Sold                     10,454   11,457    -8.8%
                                           ------   ------    ----
    Gross Profit                           13,310   12,938     2.9%
    % of Net Sales                           56.0%    53.0%

    Selling, General and Administrative
     Expense                                8,315    8,368    -0.6%
    % of Net Sales                           35.0%    34.3%

    Income from Operations                  4,995    4,570     9.3%
    % of Net Sales                           21.0%    18.7%

    Interest expense, net                     154      419
    Other income, net                         (13)    (325)

    Income Before Taxes                     4,854    4,476     8.4%

    Provision for Income Taxes              1,699    1,645

    Net Income                             $3,155   $2,831    11.4%
    % of Net Sales                           13.3%    11.6%

    Basic Earnings Per Share                $0.40    $0.35    14.3%

    Basic Weighted Average Shares
     Outstanding                            7,811    8,193

    Earnings Per Share (Diluted)            $0.40    $0.34    17.6%

    Diluted Weighted Average Shares
     Outstanding                            7,850    8,300

SOURCE Young Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Media ignores health consequences of drinking and driving among young celebrities
2. Young Innovations, Inc. Provides First Quarter Conference Call Details
3. Almost 1 in 10 Young Video Game Users Addicted
4. Transplanted liver cells function in older animals but do not proliferate as much as in younger ones
5. Less Than Half of Young Women Screened for Chlamydia
6. New Young Onset Parkinsons Disease Web Site Goes Live
7. Middle school youth as young as 12 engaging in risky sexual activity
8. Young women warned of lung cancer risks
9. Young eye researchers receive prestigious ARVO-AFER/Merck award
10. Typical Binge Drinker Is Young White Male
11. Girl Scouts of Eastern Pennsylvanias Young Womens Leadership Conference Offers a Day of Workshops on Creating A Healthier You
Post Your Comments:
(Date:10/13/2017)... Fort Worth, TX (PRWEB) , ... October 13, ... ... and financial planning agency serving communities in the greater Dallas, Miami, and Raleigh ... a young boy fighting to overcome a rare and deadly chromosome abnormality. , ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
Breaking Medicine Technology: